What a comeback! Following the release of a set of stellar 1HFY2022 financial result, Raffles Medical share price soared 17% within a week. The recovery of Raffles Medical share price must be surreal for investors as the counter collapsed spectacularly in February 2022 following the release of a set of decent financial result for FY2021.
The bearish form of Raffles Medical share price in late 2021 was attributed to the change in the COVID-19 test policy. Raffles Medical share (SGX: BSL) had ridden on the pandemic wave as the Group provides PCR swab tests services. Then again, it is always a risky business to pivot a business on pandemic measures.
In early 2022, Raffles Medical share price came under further pressure due to the lockdowns in China cities, which impacted the Group’s three hospitals in China. According to the management, Raffles Hospital Shanghai was the most impacted. To cushion the impact, the Group conducted a series of shares buybacks to rescue Raffles Medical share price. For the new financial year, the Group acquired 5.3 million of shares from the market. As at 28 June, the number of treasury shares held was 23.3 million.
With the relaxation of COVID-19 related travel protocols, the growth momentum of the Group’s COVID-19 related business would not be sustainable as the activities taper off. Take for example, revenue from the Hospital Services division decreased by 11.4% to $151.8 million, due to a decrease in the number of polymerase chain reaction (PCR) diagnostic tests carried out in 1HFY2022. Against this backdrop, what is the outlook for Raffles Medical share price for the rest of FY2022?Note that this is an opinion article and not meant to be a financial advice. Please do your due diligence or engage financial advisors before investing in the stock market. Furthermore, I am not vested and have never invested in Raffles Medical before. Whether Raffles Medical share price (SGX: BSL) will surge or collapse has no impact on me. Thus, this article is not meant to induce readers to make any form of investment decisions.
Raffles Medical share price seeing light at end of tunnel?
The latest financial result was certainly encouraging, to the extent of providing a booster shot to Raffles Medical share price. The most uplifting part should be [This is a premium article. The rest of the content is blocked and can be accessible by SG Wealth Builder Members only. To read the full content, please sign up as member.]
For members of SG Wealth Builder logging in from Apple or Mac devices, please access through this link. This allows for one-time log in only (instead of having to key in user-id and password twice).
You may sign up to become a member of SG Wealth Builder. The full benefits and privileges of SG Wealth Builder Membership:
- Access to the latest premium articles of SG Wealth Builder
- Email notifications of latest blog articles
- Request for coverage on stocks, insurance and other personal financial topics
- Comment in articles
Monthly Subscription Plan
You may sign up for the monthly subscription for only $19.99 per month! You can choose to cancel the subscription after one month with no penalty.
This plan is ideal for readers who wish to try out SG Wealth Builder Membership for a limited time. Thereafter, you may choose to upgrade to Lifetime Membership for a one-off payment. Email me (firstname.lastname@example.org) to find out more about the Lifetime Membership.
Note: After payment is made, you will be prompted with registration form to create your user-id and personal password.